480-09-1

Basic information

• Product Name: rhein-9-anthrone
• Synonyms: rhein-9-anthrone;RHEINANTHRONE;9,10-Dihydro-4,5-dihydroxy-10-oxo-2-anthracenecarboxylic acid
• CAS NO: 480-09-1
• Molecular Formula: C15H10O5
• Molecular Weight: 270.2369
• Mol File: 480-09-1.mol

Chemical Properties

• Boiling Point: 602.6°Cat760mmHg
• Flash Point: 332.3°C
• Appearance: /
• Density: 1.571g/cm³
• Vapor Pressure: 2.26E-15mmHg at 25°C
• Refractive Index: 1.738
• CAS DataBase Reference: rhein-9-anthrone(CAS DataBase Reference)
• NIST Chemistry Reference: rhein-9-anthrone(480-09-1)
• EPA Substance Registry System: rhein-9-anthrone(480-09-1)

Safety Data

• Hazardous Substances Data: 480-09-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Rhein-9-anthrone is used as a laxative for the treatment of constipation. It helps in relieving the symptoms of constipation by promoting bowel movements and facilitating the passage of stool.
Additionally, rhein-9-anthrone is hypothesized to induce cell proliferation, which may have potential implications in the field of cancer research. However, it is important to note that it is also considered a potential carcinogenic agent, and further research is needed to fully understand its effects on human health.

InChI:InChI=1/C15H10O5/c16-10-3-1-2-7-4-8-5-9(15(19)20)6-11(17)13(8)14(18)12(7)10/h1-3,5-6,16-17H,4H2,(H,19,20)

Upstream product

• 517-44-2 sennidin B 
• 81-27-6 sennoside A 
• 478-43-3 1,8-dihydroxy-3-carboxy-anthraquinone 
• 517-44-2 sennidin A 

Relevant articles and documents

The influence of the sennosides on absorption of glycyrrhetic acid in rats

In the course of our clinical studies of Kampo medicine (traditional Japanese medicines), we observed the pharmacokinetic interactions between two herbs. When Onpito (TJ-8117, Kampo medicine) containing licorice and rhubarb was administered orally to human subjects, we observed that the AUC (0-lim) and Cmax of glycyrrhetic acid (GA) in plasma were lower than those treated with other Kampo medicines containing licorice. In this study, we demonstrate the pharmacokinetic interactions of GA derived from glycyrrhizinic acid (GL) in licorice and anthraquinones derived from rhubarb. To our knowledge, this is the first report to investigate the pharmacokinetic interactions between two herbs. When GL was orally co-administrated to rats with a non-effective dose of sennoside A having purgative activity, the AUC (0-lim) and Cmax of GA decreased. In addition, sennoside A did not affect the metabolism of GL by the intestinal bacteria in vitro. In the examination using an in situ loop of rat colon, the remaining ratio of GA rose drastically by the co-administration of sennoside A, sennidin A and rhein. Observed inhibition activity of these anthraquinones on GA absorption depended on the concentration of the components added. The maximum inhibition ratio was approximately 75% by rhein, 60% by sennoside A and 25% by sennidin A. We conclude that the decrease of the pharmacokinetic parameters of GA in human plasma observed in the clinical study of TJ-8117 is attributable to an interactive action of absorption from the intestinal tract by anthraquinones contained in or derived from rhubarb.